ATE394475T1 - Methode zur herstellung von infektiösem reovirus - Google Patents

Methode zur herstellung von infektiösem reovirus

Info

Publication number: ATE394475T1
Authority: AT; Austria
Prior art keywords: producing infectious; infectious reovirus; reovirus; producing; infectious
Prior art date: 2000-08-10

Application number

AT05009952T

Other languages

English (en)

Inventor

Matthew C Coffey

Bradley G Thompson

Original Assignee

Oncolytics Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2001-07-20

Publication date

2008-05-15

2001-07-20 Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE394475T1 publication Critical patent/ATE394475T1/de

Links

241000702263 Reovirus sp. Species 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
230000002458 infectious effect Effects 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT05009952T 2000-08-10 2001-07-20 Methode zur herstellung von infektiösem reovirus ATE394475T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22402600P	2000-08-10	2000-08-10

Publications (1)

Publication Number	Publication Date
ATE394475T1 true ATE394475T1 (de)	2008-05-15

Family

ID=22838987

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT01953084T ATE298788T1 (de)	2000-08-10	2001-07-20	Verfahren zur herstellung von infektiösen reoviren
AT05009952T ATE394475T1 (de)	2000-08-10	2001-07-20	Methode zur herstellung von infektiösem reovirus

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT01953084T ATE298788T1 (de)	2000-08-10	2001-07-20	Verfahren zur herstellung von infektiösen reoviren

Country Status (18)

Country	Link
US (4)	US6528305B2 (de)
EP (2)	EP1309672B1 (de)
JP (2)	JP4009532B2 (de)
AR (1)	AR033993A1 (de)
AT (2)	ATE298788T1 (de)
AU (2)	AU2001275628B2 (de)
BR (1)	BR0113122A (de)
CA (1)	CA2415749C (de)
DE (2)	DE60133947D1 (de)
DK (2)	DK1586634T3 (de)
ES (2)	ES2241844T3 (de)
IL (2)	IL153847A0 (de)
MX (1)	MXPA03000846A (de)
NZ (1)	NZ523510A (de)
PT (2)	PT1309672E (de)
TW (1)	TWI289158B (de)
WO (1)	WO2002012435A1 (de)
ZA (1)	ZA200300410B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6545492B1 (en) *	1999-09-20	2003-04-08	Europaisches Laboratorium Fur Molekularbiologie (Embl)	Multiple local probe measuring device and method
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus
EP1370643A1 (de)	2001-03-16	2003-12-17	Oncolytics Biotech, Inc.	Methode zur extraktion von virus aus einer zellkultur
US20040115170A1 (en) *	2001-11-30	2004-06-17	Brown Earl Garnet	Oncolytic virus
US20040005546A1 (en)	2002-02-28	2004-01-08	Oncolytics Biotech Inc.	Use of ribozymes in the detection of adventitious agents
CA2374388C (en) *	2002-02-28	2005-07-12	Matthew C. Coffey	The use of ribozymes in the detection of adventitious agents
CA2426283C (en) *	2002-04-29	2006-06-27	The Trustees Of The University Of Pennsylvania	Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
DK1501921T4 (da)	2002-04-30	2012-10-08	Oncolytics Biotech Inc	Forbedrede virusrensningsmetoder
ES2239928T3 (es) *	2002-05-09	2009-02-16	Oncolytics Biotech Inc.	Metodo para reducir el dolor utilizando virus oncoliticos.
EP1944035A1 (de)	2002-05-09	2008-07-16	Oncolytics Biotech Inc.	Verfahren zur Schmerzlinderung durch onkolytische Viren
ES2386779T3 (es) *	2002-05-10	2012-08-30	Oncolytics Biotech Inc.	Sensibilización de células neoplásicas frente a la terapia de radiación con virus oncolíticos
US7901921B2 (en)	2004-10-22	2011-03-08	Oncolytics Biotech Inc.	Viral purification methods
US7490608B2 (en) *	2005-06-17	2009-02-17	Nellcorr Puritan Bennett Llc	System and method for adjusting a gas delivery mask
EP1917351A4 (de)	2005-08-01	2009-12-16	Univ Technologies Int	Abgeschwächtes reovirus
US10668119B2 (en)	2005-08-01	2020-06-02	Virocure, Inc.	Attenuated reovirus
AU2007215328A1 (en) *	2006-02-13	2007-08-23	Oncolytics Biotech Inc.	Use of local immune suppression to enhance oncolytic viral therapy
US8293498B2 (en)	2006-12-20	2012-10-23	Vanderbilt University	System for generation of viable reovirus from cloned cDNA
WO2008127486A2 (en) *	2006-12-29	2008-10-23	Bacilligen, Inc.	Replication-proficient dsrna capsids and uses thereof
CA2678721C (en)	2007-03-12	2018-02-13	Oncolytics Biotech Inc.	Reoviruses having modified sequences
US10369171B2 (en)	2007-03-13	2019-08-06	Virocure, Inc.	Attenuated reoviruses for selection of cell populations
AR066649A1 (es) *	2007-05-21	2009-09-02	Oncolytics Biotech Inc	Reovirus mutantes y metodos de elaboracion y uso de los mismos
MX2010003556A (es) *	2007-10-22	2010-04-21	Oncolytics Biotech Inc	Regimen de tratamiento para trastornos proliferantes.
US20110086005A1 (en) *	2008-05-27	2011-04-14	Oncolytics Biotech Inc.	Modulating interstitial pressure and oncolytic viral delivery and distribution
WO2009143611A1 (en) *	2008-05-27	2009-12-03	Oncolytics Biotech Inc.	Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
US9249195B2 (en)	2010-04-07	2016-02-02	Vanderbilt University	Reovirus vaccines and methods of use therefor
JP2013523175A (ja)	2010-04-14	2013-06-17	イーエムディー・ミリポア・コーポレーション	高力価、高純度のウイルスストックの作製方法及びその使用方法
CA2819246C (en)	2010-12-02	2023-04-25	Oncolytics Biotech Inc.	Liquid viral formulations
US9044498B2 (en)	2010-12-02	2015-06-02	Oncolytics Biotech Inc.	Lyophilized viral formulations
ES2796950T3 (es)	2013-11-15	2020-11-30	Oncolytics Biotech Inc	Virus oncolíticos y regímenes reforzados para tratamiento de cáncer
CN112143693B (zh) *	2019-06-28	2024-12-27	杭州康万达医药科技有限公司	一种生产病毒的方法及收获液组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4070453A (en) *	1976-06-25	1978-01-24	Syntex (U.S.A.) Inc.	Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
US4559229A (en) *	1982-07-20	1985-12-17	Research Foundation	Avian proventriculitis vaccine
US5023252A (en)	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja)	1986-08-11	1988-02-25	Biseibutsu Kagaku Kenkyusho:Kk	豚のレオウイルス感染症ワクチン
US5658779A (en)	1992-03-20	1997-08-19	Ligochem, Inc.	Method of adsorbing viruses from fluid compositions
JPH08214876A (ja)	1995-02-15	1996-08-27	Chemo Sero Therapeut Res Inst	ウイルスの調製法
JP4492826B2 (ja)	1996-11-20	2010-06-30	イントロジェンセラピューティクス，インコーポレイテッド	アデノウイルスベクターの産生および精製のための改良された方法
CA2283894A1 (en)	1997-06-24	1998-12-30	Basf Aktiengesellschaft	Method for producing 4,4' dihalogendiphenylsulfone
US6110461A (en) *	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
US6136307A (en) *	1997-08-13	2000-10-24	Oncolytics Biotech Inc.	Reovirus for the treatment of cellular proliferative disorders
AR028039A1 (es)	2000-05-03	2003-04-23	Oncolytics Biotech Inc	Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus

2001
- 2001-07-19 TW TW90117712A patent/TWI289158B/zh not_active IP Right Cessation
- 2001-07-20 WO PCT/CA2001/001054 patent/WO2002012435A1/en not_active Ceased
- 2001-07-20 AT AT01953084T patent/ATE298788T1/de not_active IP Right Cessation
- 2001-07-20 EP EP01953084A patent/EP1309672B1/de not_active Expired - Lifetime
- 2001-07-20 DE DE60133947T patent/DE60133947D1/de not_active Expired - Lifetime
- 2001-07-20 AU AU2001275628A patent/AU2001275628B2/en not_active Expired
- 2001-07-20 DK DK05009952T patent/DK1586634T3/da active
- 2001-07-20 MX MXPA03000846A patent/MXPA03000846A/es active IP Right Grant
- 2001-07-20 PT PT01953084T patent/PT1309672E/pt unknown
- 2001-07-20 JP JP2002517726A patent/JP4009532B2/ja not_active Expired - Lifetime
- 2001-07-20 AU AU7562801A patent/AU7562801A/xx active Pending
- 2001-07-20 CA CA 2415749 patent/CA2415749C/en not_active Expired - Lifetime
- 2001-07-20 ES ES01953084T patent/ES2241844T3/es not_active Expired - Lifetime
- 2001-07-20 DE DE2001611747 patent/DE60111747T2/de not_active Expired - Lifetime
- 2001-07-20 AT AT05009952T patent/ATE394475T1/de not_active IP Right Cessation
- 2001-07-20 DK DK01953084T patent/DK1309672T3/da active
- 2001-07-20 ZA ZA200300410A patent/ZA200300410B/xx unknown
- 2001-07-20 PT PT05009952T patent/PT1586634E/pt unknown
- 2001-07-20 ES ES05009952T patent/ES2305940T3/es not_active Expired - Lifetime
- 2001-07-20 BR BR0113122A patent/BR0113122A/pt not_active IP Right Cessation
- 2001-07-20 IL IL15384701A patent/IL153847A0/xx active IP Right Grant
- 2001-07-20 NZ NZ523510A patent/NZ523510A/en unknown
- 2001-07-20 EP EP20050009952 patent/EP1586634B1/de not_active Expired - Lifetime
- 2001-08-02 US US09/920,012 patent/US6528305B2/en not_active Expired - Lifetime
- 2001-08-03 AR ARP010103738 patent/AR033993A1/es active IP Right Grant
2003
- 2003-01-08 IL IL153847A patent/IL153847A/en unknown
- 2003-01-08 US US10/337,911 patent/US6703232B2/en not_active Expired - Lifetime
- 2003-12-11 US US10/734,552 patent/US7049127B2/en not_active Expired - Lifetime
2006
- 2006-03-27 US US11/390,885 patent/US7429485B2/en not_active Expired - Lifetime
- 2006-08-30 JP JP2006234596A patent/JP2006314336A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
EP1586634B1 (de)	2008-05-07
JP2004505623A (ja)	2004-02-26
IL153847A (en)	2007-10-31
AU2001275628B8 (en)	2002-02-18
EP1309672B1 (de)	2005-06-29
PT1309672E (pt)	2005-09-30
WO2002012435A1 (en)	2002-02-14
ES2305940T3 (es)	2008-11-01
EP1586634A1 (de)	2005-10-19
CA2415749C (en)	2009-05-12
IL153847A0 (en)	2003-07-31
DE60111747T2 (de)	2006-04-27
ZA200300410B (en)	2004-01-26
MXPA03000846A (es)	2004-04-05
AU7562801A (en)	2002-02-18
BR0113122A (pt)	2003-07-22
ES2241844T3 (es)	2005-11-01
JP4009532B2 (ja)	2007-11-14
US7429485B2 (en)	2008-09-30
US20060165724A1 (en)	2006-07-27
AU2001275628B2 (en)	2007-08-30
US6703232B2 (en)	2004-03-09
DK1586634T3 (da)	2008-08-18
DK1309672T3 (da)	2005-10-10
TWI289158B (en)	2007-11-01
ATE298788T1 (de)	2005-07-15
EP1309672A1 (de)	2003-05-14
US20040126869A1 (en)	2004-07-01
AR033993A1 (es)	2004-01-21
NZ523510A (en)	2004-08-27
US20030166253A1 (en)	2003-09-04
US7049127B2 (en)	2006-05-23
US20020037576A1 (en)	2002-03-28
CA2415749A1 (en)	2002-02-14
DE60111747D1 (de)	2005-08-04
US6528305B2 (en)	2003-03-04
PT1586634E (pt)	2008-06-19
HK1082765A1 (en)	2006-06-16
DE60133947D1 (de)	2008-06-19
JP2006314336A (ja)	2006-11-24

Legal Events

Date

Code

Title

Description

2008-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1586634

Country of ref document: EP

2010-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE394475T1 (de)	2008-05-15	Methode zur herstellung von infektiösem reovirus
ATE398174T1 (de)	2008-07-15	Methode zur herstellung funktioneller proteindomänen
DE60107450D1 (de)	2004-12-30	Verfahren zur herstellung von fluoroelastomeren
DE60221399D1 (de)	2007-09-06	Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de)	2008-08-15	Verfahren zur herstellung von o- desmethylvenlafaxin
DE60033061D1 (de)	2007-03-08	Verfahren zur herstellung von siloxancopolycarbonaten
ATE222899T1 (de)	2002-09-15	Verfahren zur herstellung von reinem citalopram
ATE453648T1 (de)	2010-01-15	Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
ATE281448T1 (de)	2004-11-15	Verfahren zur herstellung von citalopram
AT7110U9 (de)	2004-11-25	Verfahren zur herstellung von amlodipinmaleat
DE60230908D1 (de)	2009-03-05	Verfahren zur herstellung von polyarylenethern
DE60217213D1 (de)	2007-02-15	Methode zur Herstellung einer Fotomaske
DE50101607D1 (de)	2004-04-08	Verfahren zur herstellung von bisphenolen
DE60238628D1 (de)	2011-01-27	Methode zur herstellung von kalzium glukonat
DE50102444D1 (de)	2004-07-01	Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de)	2006-02-15	Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
ATE266004T1 (de)	2004-05-15	Verfahren zur herstellung von 3-amino-2-chlor-4- methylpyridin
DE50111560D1 (de)	2007-01-11	Verfahren zur herstellung von guerbetalkoholen
ATE389645T1 (de)	2008-04-15	Verfahren zur herstellung von citalopram
DE50200870D1 (de)	2004-09-23	Verfahren zur herstellung von hydroxyalkylpolysiloxanen
DE60123013T8 (de)	2007-09-20	Verfahren zur herstellung von glasskeramiken
DE60105991D1 (de)	2004-11-04	Verfahren zur herstellung von 6-aminocapronamid
DE60135096D1 (de)	2008-09-11	Verfahren zur herstellung von tetrafluorethylen
ATE282031T1 (de)	2004-11-15	Verfahren zur herstellung von citalopram
ATE232845T1 (de)	2003-03-15	Verfahren zur herstellung von cyclopropenen